Siemens Healthineers Expands Production Site in Rudolstadt, Germany and Creates New Jobs

Siemens HealthineersSiemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators that will be used as radiation sources for Varian's cancer therapy devices. Varian has been a Siemens Healthineers company since 2021. The hall will also expand the production line for so-called liquid metal plain bearings, a core technology of high-end computed tomography and angiography systems. The expansion of the site is expected to create around 50 new jobs by 2027. Siemens Healthineers is investing around €25 million in the 2100-square-meter manufacturing facility. The new building is to be built in a CO2-neutral manner and operated as sustainably as possible. "The expansion in Rudolstadt is a strong commitment to the location and the entire region. We want to grow here, create jobs and remain an attractive employer," says Peter Schardt, Chief Technology Officer of Siemens Healthineers and responsible for Rudolstadt as a technology location.

In order to meet the growing demand for Varian's radiotherapy equipment, the company needs a second manufacturing site for core components of its radiotherapy devices in addition to Palo Alto in the USA. In Rudolstadt, Siemens Healthineers has the necessary knowledge and already manufactures such components. The electron accelerators from Rudolstadt are to be used for the Halcyon and TrueBeam radiotherapy systems, some of which are manufactured at the Kemnath site in Germany.

Radiotherapy with so-called linear accelerators is one of the most important methods of modern cancer therapy and is used in more than half of all cancer treatments today. Linear accelerators are used both in the outpatient sector and in hospitals for the targeted treatment of cancer.

Today, around 270 employees develop and produce vacuum components, X-ray tubes and components for medical and industrial use at the Rudolstadt plant. The components are used, for example, in computed tomography, angiography systems or mammography devices. The site is also the manufacturing center for industrial electron linear accelerator systems, which are used, among others, in non-destructive material testing and scanning to check contents of shipping containers, trucks and train cars. The plant in Rudolstadt was founded in 1919.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...